- Home
- PBYI vs MPV Comparison
PBYI vs MPV Comparison
Compare PBYI & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- MPV
- Stock Information
- Founded
- PBYI 2010
- MPV 1988
- Country
- PBYI United States
- MPV United States
- Employees
- PBYI N/A
- MPV N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- MPV Finance Companies
- Sector
- PBYI Health Care
- MPV Finance
- Exchange
- PBYI Nasdaq
- MPV Nasdaq
- Market Cap
- PBYI 176.1M
- MPV 170.6M
- IPO Year
- PBYI N/A
- MPV N/A
- Fundamental
- Price
- PBYI $2.57
- MPV $16.71
- Analyst Decision
- PBYI Strong Buy
- MPV
- Analyst Count
- PBYI 1
- MPV 0
- Target Price
- PBYI $7.00
- MPV N/A
- AVG Volume (30 Days)
- PBYI 330.8K
- MPV 25.2K
- Earning Date
- PBYI 10-31-2024
- MPV 01-01-0001
- Dividend Yield
- PBYI N/A
- MPV 8.71%
- EPS Growth
- PBYI N/A
- MPV N/A
- EPS
- PBYI 0.18
- MPV 1.71
- Revenue
- PBYI $219,143,000.00
- MPV N/A
- Revenue This Year
- PBYI N/A
- MPV N/A
- Revenue Next Year
- PBYI N/A
- MPV N/A
- P/E Ratio
- PBYI $13.95
- MPV $9.35
- Revenue Growth
- PBYI N/A
- MPV N/A
- 52 Week Low
- PBYI $2.13
- MPV $11.18
- 52 Week High
- PBYI $7.73
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- PBYI 44.27
- MPV 68.16
- Support Level
- PBYI $2.48
- MPV $15.88
- Resistance Level
- PBYI $2.64
- MPV $16.95
- Average True Range (ATR)
- PBYI 0.13
- MPV 0.30
- MACD
- PBYI 0.06
- MPV 0.08
- Stochastic Oscillator
- PBYI 73.17
- MPV 83.19
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.